Humoral immune response to immunocomplexed HIV envelope glycoprotein 120

被引:20
作者
Denisova, G [1 ]
Stern, B [1 ]
Raviv, D [1 ]
Zwickel, J [1 ]
Smorodinsky, NI [1 ]
Gershoni, JM [1 ]
机构
[1] TEL AVIV UNIV, GEORGE S WISE FAC LIFE SCI, DEPT CELL RES & IMMUNOL, IL-69978 TEL AVIV, ISRAEL
关键词
D O I
10.1089/aid.1996.12.901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To further our understanding of the nature of HIV-1 immunogenicity, we injected mice with the virus envelope protein gp120 in different configurations: free, complexed with its receptor CD4, and as an immunocomplex with a monoclonal antibody directed against the V3 loop of the protein, Analyses of the polyclonal sera, as well as of monoclonal antibodies produced in each case, allowed us to conclude that the quality of the humoral immune response depended on the complexation state of the antigen. For the free gp120 and gp120-CD4 complex the responses were directed mainly toward conformational epitopes, However, gp120 immunocomplexed with anti-V3 loop MAb produced, in addition, numerous MAbs directed toward linear epitopes, Epitopes were mapped using immunoblots of gp120 cleaved with S. aureus V8 protease and a combinatorial epitope phage-display library, It was found that some of the linear epitopes had been previously identified as T cell epitopes, These results suggest that the immunocomplexed gp120 may be particularly well taken up by antigen-presenting cells, leading to the processing of the gp120 and the efficient presentation of T cell epitopes, Thus immunocomplexation should afford a means for enhancing the immunogenicity of gp120 and improving its presentation.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 54 条
  • [1] EPITOPE MAPPING AND TOPOLOGY OF BACULOVIRUS-EXPRESSED HIV-1 GP160 DETERMINED WITH A PANEL OF MURINE MONOCLONAL-ANTIBODIES
    ABACIOGLU, YH
    FOUTS, TR
    LAMAN, JD
    CLAASSEN, E
    PINCUS, SH
    MOORE, JP
    ROBY, CA
    KAMINLEWIS, R
    LEWIS, GK
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 371 - 381
  • [2] CROSS-NEUTRALIZING ANTIBODIES TO HIV-1 IN MICE AFTER IMMUNIZATION WITH GP160 ISCOMS - DISSECTION OF THE IMMUNE-RESPONSE
    AKERBLOM, L
    NARA, P
    DUNLOP, N
    MOREIN, B
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (07) : 621 - 627
  • [3] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [4] CAN AIDS BE PREVENTED BY T-CELL VACCINATION
    ATLAN, H
    GERSTEN, MJ
    SALK, PL
    SALK, J
    [J]. IMMUNOLOGY TODAY, 1993, 14 (05): : 200 - 202
  • [5] RECOMBINANT HUMAN FAB FRAGMENTS NEUTRALIZE HUMAN TYPE-1 IMMUNODEFICIENCY VIRUS INVITRO
    BARBAS, CF
    BJORLING, E
    CHIODI, F
    DUNLOP, N
    CABABA, D
    JONES, TM
    ZEBEDEE, SL
    PERSSON, MAA
    NARA, PL
    NORRBY, E
    BURTON, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (19) : 9339 - 9343
  • [6] BERETTA A, 1994, AIDS S1, V8, P133
  • [7] Berzofsky Jay A., 1993, P101
  • [8] CARBOHYDRATE DETERMINANT NEUAC-GAL-BETA(1-4) OF N-LINKED GLYCANS MODULATES THE ANTIGENIC ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120
    BOLMSTEDT, A
    OLOFSSON, S
    SJOGRENJANSSON, E
    JEANSSON, S
    SJOBLOM, I
    AKERBLOM, L
    HANSEN, JES
    HU, SL
    [J]. JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 3099 - 3105
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS VACCINES
    BOLOGNESI, DP
    [J]. ADVANCES IN VIRUS RESEARCH, VOL 42, 1993, 42 : 103 - 148
  • [10] THE CONTROL OF THE ANTIBODY ISOTYPE RESPONSE TO RECOMBINANT HUMAN-IMMUNODEFICIENCY-VIRUS GP120 ANTIGEN BY ADJUVANTS
    BOMFORD, R
    STAPLETON, M
    WINSOR, S
    MCKNIGHT, A
    ANDRONOVA, T
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) : 1765 - 1771